Bristol Myers' (BMY) application seeking approval for the Opdivo/Yervoy combo to treat unresectable hepatocellular carcinoma gets accepted for FDA...
Vous n'êtes pas connecté
Apellis (APLS) declines as CHMP issues a second negative opinion for the approval of intravitreal pegcetacoplan to treat GA in the EU. The company plans to seek re-examination of the same.
Bristol Myers' (BMY) application seeking approval for the Opdivo/Yervoy combo to treat unresectable hepatocellular carcinoma gets accepted for FDA...
Introduction There shall be a change of guard in Japan next month. With the ruling Liberal Democratic Party’s (LDP) presidential election scheduled...
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second...
One month after announcing her White House bid to succeed President Joe Biden, Vice President Kamala Harris holds a slim three-point lead over former...
MONDAY, Aug. 12, 2024 -- Advocates for the use of the psychedelic drug MDMA (midomafetamine) to treat mental health conditions were delivered a...
DHT Holdings Inc, the Bermudian-based independent crude oil tanker company, has reported a second quarter net profit of $44.5 million, which compares...
When “No” means “Yes, but . . .” I‘m one of the long-time Kamloopsians who thinks we need some new sports and entertainment facilities but...
Evolutionary biologists know why humans spend disproportionate energy on negative thoughts compared to positive: Teasing out threats, real or...
Bavarian Nordic is seeking EU approval to extend its mpox vaccine to adolescents, with plans for trials in younger children.
Updated Date: Tue, 20 Aug 2024 00:00:00 EDT